Attendance at National Cancer Institute and Children's Oncology Group Facilities for Children, Adolescents, and Young Adults with Cancer in Pennsylvania: A Population-Based Study

被引:3
作者
Rao, Pooja [1 ]
Segel, Joel E. [2 ,3 ]
McGregor, Lisa M. [1 ,3 ]
Lengerich, Eugene J. [3 ,4 ]
Drabick, Joseph J. [3 ]
Miller, Barbara [1 ,3 ,5 ]
机构
[1] Penn State Hlth Childrens Hosp, Div Pediat Hematol Oncol, 500 Univ Dr, Hershey, PA 17033 USA
[2] Penn State Univ, Dept Hlth Policy & Adm, University Pk, PA 16802 USA
[3] Penn State Canc Inst, Hershey, PA USA
[4] Penn State Coll Med, Dept Publ Hlth Sci, Hershey, PA USA
[5] Penn State Coll Med, Dept Biochem & Mol Biol, Hershey, PA USA
基金
美国国家卫生研究院;
关键词
delivery of health care; health care disparities; health care access; Pennsylvania; ACUTE LYMPHOBLASTIC-LEUKEMIA; BREAST-CANCER; GEOGRAPHIC ACCESS; OLDER ADOLESCENTS; CLINICAL-TRIALS; CARE; DISPARITIES; DIAGNOSIS; SURVIVAL; CENTERS;
D O I
10.1089/jayao.2019.0045
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Adolescents and young adults (AYAs) with cancer are a vulnerable population with decreased attendance at National Cancer Institute (NCI) comprehensive cancer centers and Children's Oncology Group (COG) facilities. Decreased attendance at NCI/COG facilities has been associated with poor cancer outcomes. The objective of this study was to evaluate cancer care patterns of AYAs compared with children, within Pennsylvania, and factors associated with attending an NCI/COG facility. Methods: Data from the Pennsylvania Cancer Registry between 2010 and 2015 for patients aged 0-39 years at cancer diagnosis were used. Primary analyses focused on age at diagnosis, insurance status, race, ethnicity, gender, cancer type, stage, diagnosis year, and distance to the NCI/COG facility. The primary outcome was receipt of care at an NCI/COG facility. Odds ratios (ORs) were calculated using multivariable logistic regression models. Sensitivity analyses were conducted to test and estimate robustness. Results: A sample of 15,002 patients, ages 0-39, was obtained, including 8857 patients (59%) who attended an NCI/COG facility. Patients were significantly less likely to attend an NCI/COG facility if they were aged 31-39 years (OR 0.054, 95% confidence interval [CI] 0.04-0.07), non-White (OR 0.890, 95% CI 0.80-0.99), Hispanic (OR 0.701, 95% CI 0.59-0.83), female (OR 0.915, 95% CI 0.84-1.00), had Medicaid insurance (OR 0.836, 95% CI 0.75-0.93), and lived further from an NCI/COG facility. Sensitivity analyses largely corroborated the performed estimates. Conclusions: AYAs with cancer in Pennsylvania have disproportionate attendance at specialized NCI/COG facilities across a variety of demographic domains. Enhancing the attendance of AYAs with cancer at these specialized centers is crucial to improve cancer outcomes.
引用
收藏
页码:47 / 54
页数:8
相关论文
共 42 条
  • [1] Adolescent and Young Adult Oncology Progress Review Group, 2006, NIH PUBLICATION, P06
  • [2] Site of oncologic Specialty care for older adolescents in Utah
    Albritton, Karen H.
    Wiggins, Charles H.
    Nelson, Harold E.
    Weeks, Jane C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (29) : 4616 - 4621
  • [3] Adolescent and Young Adult Oncology Patients: Disparities in Access to Specialized Cancer Centers
    Alvarez, Elysia
    Keegan, Theresa
    Johnston, Emily E.
    Haile, Robert
    Sanders, Lee
    Saynina, Olga
    Chamberlain, Lisa J.
    [J]. CANCER, 2017, 123 (13) : 2516 - 2523
  • [4] [Anonymous], 2016, HOSP GEN INFORM
  • [5] [Anonymous], NCI DES CANC CTR
  • [6] [Anonymous], 2006, NIH PUB
  • [7] Classification schemes for tumors diagnosed in adolescents and young adults
    Barr, RD
    Holowaty, EJ
    Birch, JM
    [J]. CANCER, 2006, 106 (07) : 1425 - 1430
  • [8] Cancer in Adolescents and Young Adults A Narrative Review of the Current Status and a View of the Future
    Barr, Ronald D.
    Ferrari, Andrea
    Ries, Lynn
    Whelan, Jeremy
    Bleyer, W. Archie
    [J]. JAMA PEDIATRICS, 2016, 170 (05) : 495 - 501
  • [9] Cancer in older adolescents and young adults: Epidemiology, diagnosis, treatment, survival, and importance of clinical trials
    Bleyer, WA
    [J]. MEDICAL AND PEDIATRIC ONCOLOGY, 2002, 38 (01): : 1 - 10
  • [10] Children's Oncology Group, LOC